Ken Kersemans

Prostate-specific membrane antigen as a potential theranostic target in a syngeneic immunocompetent murine model for oral squamous cell carcinoma

Michaël Henrotte (UGent) , David Creytens (UGent) , Hilde De Cock (UGent) , Filip De Vos (UGent) , Benedicte Descamps (UGent) , Lindsey Devisscher (UGent) , Wouter Huvenne (UGent) , Ken Kersemans (UGent) , Lieselotte Moerman (UGent) , Christian Vanhove (UGent) , et al.

(2024) OncoPoint Symposium, 10th, Abstracts.

Add to list

Impact of 18F-PSMA-11 PET/CT on management of biochemical recurrence and high-risk prostate cancer staging 18F-PSMA-11 PET/CT and impact on prostate cancer management

Kathia De Man (UGent) , Sarah Piron, Nick Van Laeken (UGent) , Louke Delrue (UGent) , Valerie Fonteyne (UGent) , Nicolaas Lumen (UGent) , Bliede Van den Broeck (UGent) , Ken Kersemans (UGent) , Piet Ost (UGent) and Vanessa Schelfhout (UGent)

(2022) MOLECULAR IMAGING AND BIOLOGY. 24(5). p.750-758

Add to list

18F-PSMA-11 Versus 68Ga-PSMA-11 positron emission tomography/computed tomography for staging and biochemical recurrence of prostate cancer : a prospective double-blind randomised cross-over trial

Kathia De Man (UGent) , Nick Van Laeken (UGent) , Vanessa Schelfhout (UGent) , Wolfgang P. Fendler, Bieke Lambert (UGent) , Ken Kersemans (UGent) , Sarah Piron, Nicolaas Lumen (UGent) , Karel Decaestecker (UGent) , Valerie Fonteyne (UGent) , et al.

(2022) EUROPEAN UROLOGY. 82(5). p.501-509

Add to list

Journal Article
A1
open access

Preclinical comparative study of [18F]AlF-PSMA-11 and [18F]PSMA-1007 in varying PSMA expressing tumors

Sarah Piron, Jeroen Verhoeven (UGent) , Jan Courtyn (UGent) , Ken Kersemans (UGent) , Benedicte Descamps (UGent) , Leen Pieters (UGent) , Anne Vral (UGent) , Christian Vanhove (UGent) and Filip De Vos (UGent)

(2022) SCIENTIFIC REPORTS. 12(1).

Add to list

Journal Article
A1
open access

Impact of the molar activity and PSMA expression level on [18F]AlF-PSMA-11 uptake in prostate cancer

Sarah Piron, Jeroen Verhoeven (UGent) , Emma De Coster (UGent) , Benedicte Descamps (UGent) , Ken Kersemans (UGent) , Leen Pieters (UGent) , Anne Vral (UGent) , Christian Vanhove (UGent) and Filip De Vos (UGent)

(2021) SCIENTIFIC REPORTS. 11(1).

Add to list

Journal Article
A1
open access

Intra-individual dynamic comparison of 18F-PSMA-11 and 68Ga-PSMA-11 in LNCaP xenograft bearing mice

Sarah Piron, Jeroen Verhoeven (UGent) , Benedicte Descamps (UGent) , Ken Kersemans (UGent) , Kathia De Man (UGent) , Nick Van Laeken (UGent) , Leen Pieters (UGent) , Anne Vral (UGent) , Christian Vanhove (UGent) and Filip De Vos (UGent)

(2020) SCIENTIFIC REPORTS. 10(1).

Add to list

Journal Article
A1
open access

Optimization of PET protocol and interrater reliability of 18F-PSMA-11 imaging of prostate cancer

Sarah Piron, Kathia De Man (UGent) , Vanessa Schelfhout (UGent) , Nick Van Laeken (UGent) , Ken Kersemans (UGent) , Eric Achten (UGent) , Filip De Vos (UGent) and Piet Ost (UGent)

(2020) EJNMMI RESEARCH. 10(1).

Add to list

Radiation dosimetry and biodistribution of 18F-PSMA-11 for PET imaging of prostate cancer

Sarah Piron, Kathia De Man (UGent) , Nick Van Laeken (UGent) , Yves D'Asseler (UGent) , Klaus Bacher (UGent) , Ken Kersemans (UGent) , Piet Ost (UGent) , Karel Decaestecker (UGent) , Pieter Deseyne, Valerie Fonteyne (UGent) , et al.

(2019) JOURNAL OF NUCLEAR MEDICINE. 60(12). p.1736-1742

Add to list

Journal Article
A1
open access

Technical feasibility of [18F]FET and [18F]FAZA PET guided radiotherapy in a F98 glioblastoma rat model

Jeroen Verhoeven (UGent) , Julie Bolcaen (UGent) , Valerie De Meulenaere (UGent) , Ken Kersemans (UGent) , Benedicte Descamps (UGent) , Sam Donche, Caroline Van den Broecke (UGent) , Tom Boterberg (UGent) , Jean-Pierre Kalala Okito (UGent) , Karel Deblaere (UGent) , et al.

(2019) RADIATION ONCOLOGY. 14.

Add to list

Biomimetic strategy towards gelatin coatings on PET : effect of protocol on coating stability and cell-interactive properties

Elena Diana Giol (UGent) , Sandra Van Vlierberghe (UGent) , Ronald E Unger, Ken Kersemans (UGent) , Filip De Vos (UGent) , Charles James Kirkpatrick and Peter Dubruel (UGent)

(2019) JOURNAL OF MATERIALS CHEMISTRY B. 7(8). p.1258-1269

Academic Bibliography

Ken Kersemans

Prostate-specific membrane antigen as a potential theranostic target in a syngeneic immunocompetent murine model for oral squamous cell carcinoma

Impact of 18F-PSMA-11 PET/CT on management of biochemical recurrence and high-risk prostate cancer staging 18F-PSMA-11 PET/CT and impact on prostate cancer management

18F-PSMA-11 Versus 68Ga-PSMA-11 positron emission tomography/computed tomography for staging and biochemical recurrence of prostate cancer : a prospective double-blind randomised cross-over trial

Preclinical comparative study of [18F]AlF-PSMA-11 and [18F]PSMA-1007 in varying PSMA expressing tumors

Impact of the molar activity and PSMA expression level on [18F]AlF-PSMA-11 uptake in prostate cancer

Intra-individual dynamic comparison of 18F-PSMA-11 and 68Ga-PSMA-11 in LNCaP xenograft bearing mice

Optimization of PET protocol and interrater reliability of 18F-PSMA-11 imaging of prostate cancer

Radiation dosimetry and biodistribution of 18F-PSMA-11 for PET imaging of prostate cancer

Technical feasibility of [18F]FET and [18F]FAZA PET guided radiotherapy in a F98 glioblastoma rat model

Biomimetic strategy towards gelatin coatings on PET : effect of protocol on coating stability and cell-interactive properties

Contents

Support

Contact